 | • レポートコード：MRC2-11QY05021 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は獣医治療のグローバル市場について調査・分析したレポートです。種類別（抗炎症剤、寄生虫駆除剤、その他）市場規模、用途別（病院、獣医クリニック、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別獣医治療の競争状況、市場シェア ・世界の獣医治療市場：種類別市場規模 2015年-2020年（抗炎症剤、寄生虫駆除剤、その他） ・世界の獣医治療市場：種類別市場規模予測 2021年-2026年（抗炎症剤、寄生虫駆除剤、その他） ・世界の獣医治療市場：用途別市場規模 2015年-2020年（病院、獣医クリニック、ドラッグストア） ・世界の獣医治療市場：用途別市場規模予測 2021年-2026年（病院、獣医クリニック、ドラッグストア） ・北米の獣医治療市場分析：米国、カナダ ・ヨーロッパの獣医治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの獣医治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の獣医治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの獣医治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer AG、Boehringer Ingelheim GmbH、Ceva Sante Animale、Dechra Pharmaceuticals PLC、Eli Lilly and Company (Elanco Animal Health)、Merck Animal Health、Sanofi (Merial Animal Health)、Virbac、Vetoquinol S.A.、Zoetis, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Veterinary Therapeutics Market
The global Veterinary Therapeutics market size is projected to reach US$ 30990 million by 2026, from US$ 29770 million in 2020, at a CAGR of 3.8%% during 2021-2026.
Global Veterinary Therapeutics Scope and Market Size
Veterinary Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bayer AG
Boehringer Ingelheim GmbH
Ceva Sante Animale
Dechra Pharmaceuticals PLC
Eli Lilly and Company (Elanco Animal Health)
Merck Animal Health
Sanofi (Merial Animal Health)
Virbac
Vetoquinol S.A.
Zoetis, Inc.
Market segment by Type, the product can be split into
Anti-inflammatory
Parasiticides
Other
Market segment by Application, split into
Hospitals
Veterinary Clinics
Drug Stores
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Veterinary Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Veterinary Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anti-inflammatory
1.4.3 Parasiticides
1.4.4 Other
1.5 Market by Application
1.5.1 Global Veterinary Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Veterinary Clinics
1.5.4 Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Therapeutics Market Perspective (2015-2026)
2.2 Global Veterinary Therapeutics Growth Trends by Regions
2.2.1 Veterinary Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Veterinary Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Veterinary Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Veterinary Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Veterinary Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Therapeutics Players by Market Size
3.1.1 Global Top Veterinary Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Veterinary Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Veterinary Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Veterinary Therapeutics Market Concentration Ratio
3.2.1 Global Veterinary Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Veterinary Therapeutics Revenue in 2019
3.3 Veterinary Therapeutics Key Players Head office and Area Served
3.4 Key Players Veterinary Therapeutics Product Solution and Service
3.5 Date of Enter into Veterinary Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Veterinary Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Veterinary Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Veterinary Therapeutics Market Size by Application (2015-2020)
5.2 Global Veterinary Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Veterinary Therapeutics Market Size (2015-2020)
6.2 Veterinary Therapeutics Key Players in North America (2019-2020)
6.3 North America Veterinary Therapeutics Market Size by Type (2015-2020)
6.4 North America Veterinary Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Veterinary Therapeutics Market Size (2015-2020)
7.2 Veterinary Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Veterinary Therapeutics Market Size by Type (2015-2020)
7.4 Europe Veterinary Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Veterinary Therapeutics Market Size (2015-2020)
8.2 Veterinary Therapeutics Key Players in China (2019-2020)
8.3 China Veterinary Therapeutics Market Size by Type (2015-2020)
8.4 China Veterinary Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Veterinary Therapeutics Market Size (2015-2020)
9.2 Veterinary Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Veterinary Therapeutics Market Size by Type (2015-2020)
9.4 Japan Veterinary Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Veterinary Therapeutics Market Size (2015-2020)
10.2 Veterinary Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Veterinary Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Veterinary Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Veterinary Therapeutics Market Size (2015-2020)
11.2 Veterinary Therapeutics Key Players in India (2019-2020)
11.3 India Veterinary Therapeutics Market Size by Type (2015-2020)
11.4 India Veterinary Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Veterinary Therapeutics Market Size (2015-2020)
12.2 Veterinary Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Veterinary Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Veterinary Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bayer AG
13.1.1 Bayer AG Company Details
13.1.2 Bayer AG Business Overview
13.1.3 Bayer AG Veterinary Therapeutics Introduction
13.1.4 Bayer AG Revenue in Veterinary Therapeutics Business (2015-2020))
13.1.5 Bayer AG Recent Development
13.2 Boehringer Ingelheim GmbH
13.2.1 Boehringer Ingelheim GmbH Company Details
13.2.2 Boehringer Ingelheim GmbH Business Overview
13.2.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Introduction
13.2.4 Boehringer Ingelheim GmbH Revenue in Veterinary Therapeutics Business (2015-2020)
13.2.5 Boehringer Ingelheim GmbH Recent Development
13.3 Ceva Sante Animale
13.3.1 Ceva Sante Animale Company Details
13.3.2 Ceva Sante Animale Business Overview
13.3.3 Ceva Sante Animale Veterinary Therapeutics Introduction
13.3.4 Ceva Sante Animale Revenue in Veterinary Therapeutics Business (2015-2020)
13.3.5 Ceva Sante Animale Recent Development
13.4 Dechra Pharmaceuticals PLC
13.4.1 Dechra Pharmaceuticals PLC Company Details
13.4.2 Dechra Pharmaceuticals PLC Business Overview
13.4.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Introduction
13.4.4 Dechra Pharmaceuticals PLC Revenue in Veterinary Therapeutics Business (2015-2020)
13.4.5 Dechra Pharmaceuticals PLC Recent Development
13.5 Eli Lilly and Company (Elanco Animal Health)
13.5.1 Eli Lilly and Company (Elanco Animal Health) Company Details
13.5.2 Eli Lilly and Company (Elanco Animal Health) Business Overview
13.5.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Introduction
13.5.4 Eli Lilly and Company (Elanco Animal Health) Revenue in Veterinary Therapeutics Business (2015-2020)
13.5.5 Eli Lilly and Company (Elanco Animal Health) Recent Development
13.6 Merck Animal Health
13.6.1 Merck Animal Health Company Details
13.6.2 Merck Animal Health Business Overview
13.6.3 Merck Animal Health Veterinary Therapeutics Introduction
13.6.4 Merck Animal Health Revenue in Veterinary Therapeutics Business (2015-2020)
13.6.5 Merck Animal Health Recent Development
13.7 Sanofi (Merial Animal Health)
13.7.1 Sanofi (Merial Animal Health) Company Details
13.7.2 Sanofi (Merial Animal Health) Business Overview
13.7.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Introduction
13.7.4 Sanofi (Merial Animal Health) Revenue in Veterinary Therapeutics Business (2015-2020)
13.7.5 Sanofi (Merial Animal Health) Recent Development
13.8 Virbac
13.8.1 Virbac Company Details
13.8.2 Virbac Business Overview
13.8.3 Virbac Veterinary Therapeutics Introduction
13.8.4 Virbac Revenue in Veterinary Therapeutics Business (2015-2020)
13.8.5 Virbac Recent Development
13.9 Vetoquinol S.A.
13.9.1 Vetoquinol S.A. Company Details
13.9.2 Vetoquinol S.A. Business Overview
13.9.3 Vetoquinol S.A. Veterinary Therapeutics Introduction
13.9.4 Vetoquinol S.A. Revenue in Veterinary Therapeutics Business (2015-2020)
13.9.5 Vetoquinol S.A. Recent Development
13.10 Zoetis, Inc.
13.10.1 Zoetis, Inc. Company Details
13.10.2 Zoetis, Inc. Business Overview
13.10.3 Zoetis, Inc. Veterinary Therapeutics Introduction
13.10.4 Zoetis, Inc. Revenue in Veterinary Therapeutics Business (2015-2020)
13.10.5 Zoetis, Inc. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Veterinary Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Veterinary Therapeutics Revenue
Table 3. Ranking of Global Top Veterinary Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Veterinary Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anti-inflammatory
Table 6. Key Players of Parasiticides
Table 7. Key Players of Other
Table 8. Global Veterinary Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Veterinary Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Veterinary Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Veterinary Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Veterinary Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Veterinary Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Veterinary Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Veterinary Therapeutics Players
Table 19. Global Veterinary Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Veterinary Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Veterinary Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Therapeutics as of 2019)
Table 22. Global Veterinary Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Veterinary Therapeutics Product Solution and Service
Table 25. Date of Enter into Veterinary Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Veterinary Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Veterinary Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Veterinary Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Veterinary Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Veterinary Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Veterinary Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Veterinary Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Veterinary Therapeutics Market Share (2019-2020)
Table 35. North America Veterinary Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Veterinary Therapeutics Market Share by Type (2015-2020)
Table 37. North America Veterinary Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Veterinary Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Veterinary Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Veterinary Therapeutics Market Share (2019-2020)
Table 41. Europe Veterinary Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Veterinary Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Veterinary Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Veterinary Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Veterinary Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Veterinary Therapeutics Market Share (2019-2020)
Table 47. China Veterinary Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Veterinary Therapeutics Market Share by Type (2015-2020)
Table 49. China Veterinary Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Veterinary Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Veterinary Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Veterinary Therapeutics Market Share (2019-2020)
Table 53. Japan Veterinary Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Veterinary Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Veterinary Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Veterinary Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Veterinary Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Veterinary Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Veterinary Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Veterinary Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Veterinary Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Veterinary Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Veterinary Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Veterinary Therapeutics Market Share (2019-2020)
Table 65. India Veterinary Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Veterinary Therapeutics Market Share by Type (2015-2020)
Table 67. India Veterinary Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Veterinary Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Veterinary Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Veterinary Therapeutics Market Share (2019-2020)
Table 71. Central & South America Veterinary Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Veterinary Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Veterinary Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Veterinary Therapeutics Market Share by Application (2015-2020)
Table 75. Bayer AG Company Details
Table 76. Bayer AG Business Overview
Table 77. Bayer AG Product
Table 78. Bayer AG Revenue in Veterinary Therapeutics Business (2015-2020) (Million US$)
Table 79. Bayer AG Recent Development
Table 80. Boehringer Ingelheim GmbH Company Details
Table 81. Boehringer Ingelheim GmbH Business Overview
Table 82. Boehringer Ingelheim GmbH Product
Table 83. Boehringer Ingelheim GmbH Revenue in Veterinary Therapeutics Business (2015-2020) (Million US$)
Table 84. Boehringer Ingelheim GmbH Recent Development
Table 85. Ceva Sante Animale Company Details
Table 86. Ceva Sante Animale Business Overview
Table 87. Ceva Sante Animale Product
Table 88. Ceva Sante Animale Revenue in Veterinary Therapeutics Business (2015-2020) (Million US$)
Table 89. Ceva Sante Animale Recent Development
Table 90. Dechra Pharmaceuticals PLC Company Details
Table 91. Dechra Pharmaceuticals PLC Business Overview
Table 92. Dechra Pharmaceuticals PLC Product
Table 93. Dechra Pharmaceuticals PLC Revenue in Veterinary Therapeutics Business (2015-2020) (Million US$)
Table 94. Dechra Pharmaceuticals PLC Recent Development
Table 95. Eli Lilly and Company (Elanco Animal Health) Company Details
Table 96. Eli Lilly and Company (Elanco Animal Health) Business Overview
Table 97. Eli Lilly and Company (Elanco Animal Health) Product
Table 98. Eli Lilly and Company (Elanco Animal Health) Revenue in Veterinary Therapeutics Business (2015-2020) (Million US$)
Table 99. Eli Lilly and Company (Elanco Animal Health) Recent Development
Table 100. Merck Animal Health Company Details
Table 101. Merck Animal Health Business Overview
Table 102. Merck Animal Health Product
Table 103. Merck Animal Health Revenue in Veterinary Therapeutics Business (2015-2020) (Million US$)
Table 104. Merck Animal Health Recent Development
Table 105. Sanofi (Merial Animal Health) Company Details
Table 106. Sanofi (Merial Animal Health) Business Overview
Table 107. Sanofi (Merial Animal Health) Product
Table 108. Sanofi (Merial Animal Health) Revenue in Veterinary Therapeutics Business (2015-2020) (Million US$)
Table 109. Sanofi (Merial Animal Health) Recent Development
Table 110. Virbac Business Overview
Table 111. Virbac Product
Table 112. Virbac Company Details
Table 113. Virbac Revenue in Veterinary Therapeutics Business (2015-2020) (Million US$)
Table 114. Virbac Recent Development
Table 115. Vetoquinol S.A. Company Details
Table 116. Vetoquinol S.A. Business Overview
Table 117. Vetoquinol S.A. Product
Table 118. Vetoquinol S.A. Revenue in Veterinary Therapeutics Business (2015-2020) (Million US$)
Table 119. Vetoquinol S.A. Recent Development
Table 120. Zoetis, Inc. Company Details
Table 121. Zoetis, Inc. Business Overview
Table 122. Zoetis, Inc. Product
Table 123. Zoetis, Inc. Revenue in Veterinary Therapeutics Business (2015-2020) (Million US$)
Table 124. Zoetis, Inc. Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Veterinary Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Anti-inflammatory Features
Figure 3. Parasiticides Features
Figure 4. Other Features
Figure 5. Global Veterinary Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Veterinary Clinics Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. Veterinary Therapeutics Report Years Considered
Figure 10. Global Veterinary Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Veterinary Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Veterinary Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Veterinary Therapeutics Market Share by Players in 2019
Figure 15. Global Top Veterinary Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Veterinary Therapeutics Revenue in 2019
Figure 17. North America Veterinary Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Veterinary Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Veterinary Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Veterinary Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Veterinary Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Veterinary Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Veterinary Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
獣医感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Veterinary Infectious Disease Therapeutics Market The global Veterinary Infectious Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veterinary Infectious Disease…- 獣医用手術器具の世界市場（～2026年） An assortment of veterinary hardware and disposables are required on a continuous reason for legitimate finding and treatment of creature infections. Rising pet possessions, developing pervasiveness of creature issue, for example, rabies, flea and trick bone infection, joint inflammation, dental mal…
- 獣医用インキュベーターの世界市場（～2026年） Veterinary Incubators are devices used to maintain optimum temperature and humidity for development and growth of the premature animals. Global Veterinary Incubators market has witnessed a robust growth due to raising awareness. Veterinary Incubators market has a presence of many regional players wh…
- 獣医クロストリジウムワクチンの世界市場（～2026年） Market Analysis and Insights: Global Veterinary Clostridium Vaccine Market The global Veterinary Clostridium Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veterinary Clostridium Vaccine Scope and Market Size …
- 獣医用ワクチンの世界市場（～2026年） Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock product…